Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;35(2):105-116.
doi: 10.1007/s12928-020-00653-7. Epub 2020 Mar 3.

Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics

Affiliations

Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics

Nobuaki Suzuki et al. Cardiovasc Interv Ther. 2020 Apr.

Abstract

Quantitative coronary angiography (QCA) remains to play an important role in clinical trials and post-marketing surveillance related to the safety and efficacy of new PCI devices. In this document, the current standard methodology of QCA is summarized. In addition, its history, recent development and future perspectives are also reviewed.

Keywords: Coronary artery disease; Coronary artery stents; Expert consensus document; Quantitative coronary angiography.

PubMed Disclaimer

Conflict of interest statement

All authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

Fig. 1
Fig. 1
History of quantitative coronary angiography. Quantitative coronary angiography (QCA) originated from the basic concept of showing objective numerical data in addition to a visual assessment. The emergence of metallic stents and drug-eluting stents has further increased its utility. As shown by the number of articles available in PubMed, even after the introduction of intravascular imaging and fractional flow reserve, QCA has maintained its value by applying three-dimensional QCA technology. FFR fractional flow reserve, PCI percutaneous coronary intervention
Fig. 2
Fig. 2
Standard scheme of measurement data. PCI percutaneous coronary intervention
Fig. 3
Fig. 3
A representative case of diffuse lesion. When the automated obstruction length and reference diameter are too underestimated at baseline, appropriate correction of the lesion length should be considered. When the in-stent restenosis appears proximally on diffuse lesion, the value of late lumen loss is usually unremarkable, whereas the diameter of stenosis is prominent. This discrepancy is so-called the previously reported “relocation” of the minimal lumen diameter. MLD minimal lumen diameter, RD reference diameter, DS diameter stenosis
Fig. 4
Fig. 4
An example of total occlusive lesion. RD reference diameter, DS diameter stenosis
Fig. 5
Fig. 5
Bifurcation analyses using bifurcation-dedicated algorithms on a QAngio® XA and b CAAS®
Fig. 6
Fig. 6
Subsegments defined using bifurcation-dedicated algorithms on a QAngio® XA and b CAAS®. a QAngio® XA provides two different bifurcation analysis models (T-shape model and Y-shape model) that are applied according to the morphology of the bifurcation. b CAAS® reports two different segment models (6- and 11-segment model). POC polygon of confluence
Fig. 7
Fig. 7
Quantitative flow ratio on QAngio® XA. The quantitative flow ratio (QFR) is computed based on three-dimensional angiography reconstructed from two different projections with angles ≥ 25° apart and volumetric flow rate calculated using a contrast bolus frame count. The QFR reports virtual color-coded pullbacks of FFR of the arteries with stenosis for which angiography were performed, without the use of a pressure wire or hyperemia

Similar articles

Cited by

References

    1. Byrne RA, Serruys PW, Baumbach A, Escaned J, Fajadet J, James S, et al. Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. Eur Heart J. 2015;36:2608–2620. - PubMed
    1. Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, et al. Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 Consensus Document. Circulation. 2018;137:2635–2650. - PubMed
    1. Farb A, Zuckerman BD. Clinical event adjudication in cardiovascular device trials: an Food and Drug Administration perspective. Am Heart J. 2017;191:62–64. - PubMed
    1. West JW, Guzman SV. Coronary dilatation and constriction visualized by selective arteriography. Circ Res. 1959;7:527–536. - PubMed
    1. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975;51:5–40. - PubMed

Publication types

MeSH terms

LinkOut - more resources